Virtual screening and zebrafish phenotype-based evaluation argues against repurposing 4-phenylbutyrate for STXBP1-relateddisorders
Aline Frick, Paige Whyte‐Fagundes, Scott C. Baraban
The paper evaluates 4-PBA and its analogs for treating STXBP1 disorders using zebrafish models and finds no rescue of movement or seizure phenotypes.